BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li ZP, Luo C, Yu XM, Ye LY, Sun D, Duan CZ, Xu SY, Zeng MQ, Xu H, Peng ZY, Wang P, Wang YB, Ruan WJ, Xue ME, Zhang CJ, He DJ. Diabetic bone fragility through advanced glycation end product-collagen axis: Mechanisms and therapy of sodium glucose cotransporter 2 inhibitors. World J Diabetes 2025; 16(10): 111813 [PMID: 41113476 DOI: 10.4239/wjd.v16.i10.111813]
URL: https://www.wjgnet.com/1948-9358/full/v16/i10/111813.htm
Number Citing Articles
1
Hind Alshamsi, Duha Alnaqbi, Charu Sharma, Romona D Govender, Raya Almazrouei. Romosozumab Efficacy in Osteoporosis: Influence of Diabetes and Previous Antiresorptive Therapy: A Single Centre ExperienceClinical Medicine Insights: Endocrinology and Diabetes 2026; 19 doi: 10.1177/11795514261440728
2
Mohammad N Khan, Anisha Tanwar, Mandayal Jamatia. Association of Bone Metabolism Markers with Glycemic Parameters in Type 2 Diabetes Mellitus: Insights from a Cross-sectional Study on Serum Osteocalcin, Vitamin D, and Parathyroid HormoneIndian Journal of Medical Biochemistry 2026; 30(2): 172 doi: 10.5005/jp-journals-10054-0329
3
彩霞 马. Effects of Different Antidiabetic Drugs on Sarcopenia and Bone MetabolismAdvances in Clinical Medicine 2026; 16(02): 1414 doi: 10.12677/acm.2026.162528
4
Han Su, Chengfeng Fu, Pingping Wang, Yingying Zhang. Long-term trajectories and cumulative exposure of the triglyceride–glucose–frailty index in relation to hip fracture risk: evidence from a large-scale population-based cohortArchives of Osteoporosis 2026; 21(1) doi: 10.1007/s11657-026-01683-z
Write to the Help Desk